The European Space Agency's Rosetta probe, launched in March 2004, will be awakened from a deep sleep next month in preparation for a rendezvous with comet 67P/Churyumov-Gerasimenko, which will culminate late next year with the first-ever soft landing on such a body.
The 6,600-pound spacecraft, which has spent nearly a decade making repeated flybys of Earth and Mars to gain enough speed to catch the comet, was put in hibernation in July 2011, after its last major gravity-assist maneuver.
Rosetta's wake up call is set for Jan. 20, 2014 at precisely 1000 GMT (5 a.m. EST).
To figure out how diet influences the microbiome, scientists put volunteers on two extreme diets: one that included only meat, egg and cheese and one that contained only grains, vegetables and legumes.
This is TELL ME MORE from NPR News. I'm Celeste Headlee. Michel Martin is away. Maybe at some point, you've gotten upset about a political issue, and you decided to write your congressman or congresswoman. That used to mean you grabbed your pen, paper, an envelope, a stamp.
Tell Me More's social storytelling series is happening online using #NPRBlacksinTech. Since December 2nd, black tech innovators from all over the country have spent a day tweeting about their lives. The social media series is creating new storytelling opportunities that run parallel to what Tell Me More does every day on the radio.
In Russia, organizers of the 2014 Winter Olympics have called on dozens of shamans to pray for snow. But the centerpiece of the Olympic snow strategy is man-made: a massive system that features more than 550 snow-making machines.
Sochi, Russia, which is hosting the Olympics, is a resort town on the relatively warm Black Sea. There are beaches and palm trees. The Alpine events will be held on a mountain just 30 minutes away, where last February it was raining, not snowing.
The Ivy League school has begun vaccinating nearly 6,000 students to try to stop an outbreak of type B meningitis in an unusual federal government-endorsed administration of a drug not generally approved for use in the U.S.
Originally published on Tue December 10, 2013 3:49 pm
Princeton University has started vaccinating students against type B meningitis in an effort to stop an outbreak that's infected at least eight people.
The vaccine isn't approved for general use in the United States, though it is available in Europe, Australia and Canada. But the meningitis strain that hit the New Jersey campus isn't fazed by the vaccines typically used in the U.S. The Food and Drug Administration is allowing a Novartis vaccine that's usually sold in other countries to be administered on the Princeton campus.